Dermatophytic Onychomycosis Market, Global Outlook and Forecast 2023-2028

Report ID: 1140473 | Published Date: Jan 2025 | No. of Page: 61 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Introduction to Research & Analysis Reports
    1.1 Dermatophytic Onychomycosis Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Dermatophytic Onychomycosis Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Dermatophytic Onychomycosis Overall Market Size
    2.1 Global Dermatophytic Onychomycosis Market Size: 2021 VS 2028
    2.2 Global Dermatophytic Onychomycosis Market Size, Prospects & Forecasts: 2017-2028
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top Dermatophytic Onychomycosis Players in Global Market
    3.2 Top Global Dermatophytic Onychomycosis Companies Ranked by Revenue
    3.3 Global Dermatophytic Onychomycosis Revenue by Companies
    3.4 Top 3 and Top 5 Dermatophytic Onychomycosis Companies in Global Market, by Revenue in 2021
    3.5 Global Companies Dermatophytic Onychomycosis Product Type
    3.6 Tier 1, Tier 2 and Tier 3 Dermatophytic Onychomycosis Players in Global Market
        3.6.1 List of Global Tier 1 Dermatophytic Onychomycosis Companies
        3.6.2 List of Global Tier 2 and Tier 3 Dermatophytic Onychomycosis Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 by Type - Global Dermatophytic Onychomycosis Market Size Markets, 2021 & 2028
        4.1.2 Oral Medicine
        4.1.3 External Medicine
    4.2 By Type - Global Dermatophytic Onychomycosis Revenue & Forecasts
        4.2.1 By Type - Global Dermatophytic Onychomycosis Revenue, 2017-2022
        4.2.2 By Type - Global Dermatophytic Onychomycosis Revenue, 2023-2028
        4.2.3 By Type - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Dermatophytic Onychomycosis Market Size, 2021 & 2028
        5.1.2 Age Under 18
        5.1.3 Age 18-50
        5.1.4 Age Above 50
    5.2 By Application - Global Dermatophytic Onychomycosis Revenue & Forecasts
        5.2.1 By Application - Global Dermatophytic Onychomycosis Revenue, 2017-2022
        5.2.2 By Application - Global Dermatophytic Onychomycosis Revenue, 2023-2028
        5.2.3 By Application - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
6 Sights by Region
    6.1 By Region - Global Dermatophytic Onychomycosis Market Size, 2021 & 2028
    6.2 By Region - Global Dermatophytic Onychomycosis Revenue & Forecasts
        6.2.1 By Region - Global Dermatophytic Onychomycosis Revenue, 2017-2022
        6.2.2 By Region - Global Dermatophytic Onychomycosis Revenue, 2023-2028
        6.2.3 By Region - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    6.3 North America
        6.3.1 By Country - North America Dermatophytic Onychomycosis Revenue, 2017-2028
        6.3.2 US Dermatophytic Onychomycosis Market Size, 2017-2028
        6.3.3 Canada Dermatophytic Onychomycosis Market Size, 2017-2028
        6.3.4 Mexico Dermatophytic Onychomycosis Market Size, 2017-2028
    6.4 Europe
        6.4.1 By Country - Europe Dermatophytic Onychomycosis Revenue, 2017-2028
        6.4.2 Germany Dermatophytic Onychomycosis Market Size, 2017-2028
        6.4.3 France Dermatophytic Onychomycosis Market Size, 2017-2028
        6.4.4 U.K. Dermatophytic Onychomycosis Market Size, 2017-2028
        6.4.5 Italy Dermatophytic Onychomycosis Market Size, 2017-2028
        6.4.6 Russia Dermatophytic Onychomycosis Market Size, 2017-2028
        6.4.7 Nordic Countries Dermatophytic Onychomycosis Market Size, 2017-2028
        6.4.8 Benelux Dermatophytic Onychomycosis Market Size, 2017-2028
    6.5 Asia
        6.5.1 By Region - Asia Dermatophytic Onychomycosis Revenue, 2017-2028
        6.5.2 China Dermatophytic Onychomycosis Market Size, 2017-2028
        6.5.3 Japan Dermatophytic Onychomycosis Market Size, 2017-2028
        6.5.4 South Korea Dermatophytic Onychomycosis Market Size, 2017-2028
        6.5.5 Southeast Asia Dermatophytic Onychomycosis Market Size, 2017-2028
        6.5.6 India Dermatophytic Onychomycosis Market Size, 2017-2028
    6.6 South America
        6.6.1 By Country - South America Dermatophytic Onychomycosis Revenue, 2017-2028
        6.6.2 Brazil Dermatophytic Onychomycosis Market Size, 2017-2028
        6.6.3 Argentina Dermatophytic Onychomycosis Market Size, 2017-2028
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa Dermatophytic Onychomycosis Revenue, 2017-2028
        6.7.2 Turkey Dermatophytic Onychomycosis Market Size, 2017-2028
        6.7.3 Israel Dermatophytic Onychomycosis Market Size, 2017-2028
        6.7.4 Saudi Arabia Dermatophytic Onychomycosis Market Size, 2017-2028
        6.7.5 UAE Dermatophytic Onychomycosis Market Size, 2017-2028
7 Players Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Corporate Summary
        7.1.2 Johnson & Johnson Business Overview
        7.1.3 Johnson & Johnson Dermatophytic Onychomycosis Major Product Offerings
        7.1.4 Johnson & Johnson Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.1.5 Johnson & Johnson Key News
    7.2 GSK
        7.2.1 GSK Corporate Summary
        7.2.2 GSK Business Overview
        7.2.3 GSK Dermatophytic Onychomycosis Major Product Offerings
        7.2.4 GSK Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.2.5 GSK Key News
    7.3 Novartis
        7.3.1 Novartis Corporate Summary
        7.3.2 Novartis Business Overview
        7.3.3 Novartis Dermatophytic Onychomycosis Major Product Offerings
        7.3.4 Novartis Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.3.5 Novartis Key News
    7.4 Pfizer
        7.4.1 Pfizer Corporate Summary
        7.4.2 Pfizer Business Overview
        7.4.3 Pfizer Dermatophytic Onychomycosis Major Product Offerings
        7.4.4 Pfizer Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.4.5 Pfizer Key News
    7.5 Bausch Health
        7.5.1 Bausch Health Corporate Summary
        7.5.2 Bausch Health Business Overview
        7.5.3 Bausch Health Dermatophytic Onychomycosis Major Product Offerings
        7.5.4 Bausch Health Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.5.5 Bausch Health Key News
    7.6 Kaken Pharmaceutical
        7.6.1 Kaken Pharmaceutical Corporate Summary
        7.6.2 Kaken Pharmaceutical Business Overview
        7.6.3 Kaken Pharmaceutical Dermatophytic Onychomycosis Major Product Offerings
        7.6.4 Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.6.5 Kaken Pharmaceutical Key News
    7.7 Galderma
        7.7.1 Galderma Corporate Summary
        7.7.2 Galderma Business Overview
        7.7.3 Galderma Dermatophytic Onychomycosis Major Product Offerings
        7.7.4 Galderma Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.7.5 Galderma Key News
    7.8 Sanofi
        7.8.1 Sanofi Corporate Summary
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Dermatophytic Onychomycosis Major Product Offerings
        7.8.4 Sanofi Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.8.5 Sanofi Key News
    7.9 Allergan
        7.9.1 Allergan Corporate Summary
        7.9.2 Allergan Business Overview
        7.9.3 Allergan Dermatophytic Onychomycosis Major Product Offerings
        7.9.4 Allergan Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.9.5 Allergan Key News
    7.10 Merz Pharma
        7.10.1 Merz Pharma Corporate Summary
        7.10.2 Merz Pharma Business Overview
        7.10.3 Merz Pharma Dermatophytic Onychomycosis Major Product Offerings
        7.10.4 Merz Pharma Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.10.5 Merz Pharma Key News
    7.11 Xiuzheng Pharmaceutical
        7.11.1 Xiuzheng Pharmaceutical Corporate Summary
        7.11.2 Xiuzheng Pharmaceutical Business Overview
        7.11.3 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Major Product Offerings
        7.11.4 Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.11.5 Xiuzheng Pharmaceutical Key News
    7.12 Letai
        7.12.1 Letai Corporate Summary
        7.12.2 Letai Business Overview
        7.12.3 Letai Dermatophytic Onychomycosis Major Product Offerings
        7.12.4 Letai Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.12.5 Letai Key News
    7.13 Qilu Pharmaceutical
        7.13.1 Qilu Pharmaceutical Corporate Summary
        7.13.2 Qilu Pharmaceutical Business Overview
        7.13.3 Qilu Pharmaceutical Dermatophytic Onychomycosis Major Product Offerings
        7.13.4 Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue in Global Market (2017-2022)
        7.13.5 Qilu Pharmaceutical Key News
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer

List of Tables
    Table 1. Dermatophytic Onychomycosis Market Opportunities & Trends in Global Market
    Table 2. Dermatophytic Onychomycosis Market Drivers in Global Market
    Table 3. Dermatophytic Onychomycosis Market Restraints in Global Market
    Table 4. Key Players of Dermatophytic Onychomycosis in Global Market
    Table 5. Top Dermatophytic Onychomycosis Players in Global Market, Ranking by Revenue (2021)
    Table 6. Global Dermatophytic Onychomycosis Revenue by Companies, (US$, Mn), 2017-2022
    Table 7. Global Dermatophytic Onychomycosis Revenue Share by Companies, 2017-2022
    Table 8. Global Companies Dermatophytic Onychomycosis Product Type
    Table 9. List of Global Tier 1 Dermatophytic Onychomycosis Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 10. List of Global Tier 2 and Tier 3 Dermatophytic Onychomycosis Companies, Revenue (US$, Mn) in 2021 and Market Share
    Table 11. By Type – Global Dermatophytic Onychomycosis Revenue, (US$, Mn), 2021 & 2028
    Table 12. By Type - Dermatophytic Onychomycosis Revenue in Global (US$, Mn), 2017-2022
    Table 13. By Type - Dermatophytic Onychomycosis Revenue in Global (US$, Mn), 2023-2028
    Table 14. By Application – Global Dermatophytic Onychomycosis Revenue, (US$, Mn), 2021 & 2028
    Table 15. By Application - Dermatophytic Onychomycosis Revenue in Global (US$, Mn), 2017-2022
    Table 16. By Application - Dermatophytic Onychomycosis Revenue in Global (US$, Mn), 2023-2028
    Table 17. By Region – Global Dermatophytic Onychomycosis Revenue, (US$, Mn), 2021 & 2028
    Table 18. By Region - Global Dermatophytic Onychomycosis Revenue (US$, Mn), 2017-2022
    Table 19. By Region - Global Dermatophytic Onychomycosis Revenue (US$, Mn), 2023-2028
    Table 20. By Country - North America Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
    Table 21. By Country - North America Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
    Table 22. By Country - Europe Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
    Table 23. By Country - Europe Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
    Table 24. By Region - Asia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
    Table 25. By Region - Asia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
    Table 26. By Country - South America Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
    Table 27. By Country - South America Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
    Table 28. By Country - Middle East & Africa Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2022
    Table 29. By Country - Middle East & Africa Dermatophytic Onychomycosis Revenue, (US$, Mn), 2023-2028
    Table 30. Johnson & Johnson Corporate Summary
    Table 31. Johnson & Johnson Dermatophytic Onychomycosis Product Offerings
    Table 32. Johnson & Johnson Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 33. GSK Corporate Summary
    Table 34. GSK Dermatophytic Onychomycosis Product Offerings
    Table 35. GSK Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 36. Novartis Corporate Summary
    Table 37. Novartis Dermatophytic Onychomycosis Product Offerings
    Table 38. Novartis Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 39. Pfizer Corporate Summary
    Table 40. Pfizer Dermatophytic Onychomycosis Product Offerings
    Table 41. Pfizer Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 42. Bausch Health Corporate Summary
    Table 43. Bausch Health Dermatophytic Onychomycosis Product Offerings
    Table 44. Bausch Health Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 45. Kaken Pharmaceutical Corporate Summary
    Table 46. Kaken Pharmaceutical Dermatophytic Onychomycosis Product Offerings
    Table 47. Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 48. Galderma Corporate Summary
    Table 49. Galderma Dermatophytic Onychomycosis Product Offerings
    Table 50. Galderma Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 51. Sanofi Corporate Summary
    Table 52. Sanofi Dermatophytic Onychomycosis Product Offerings
    Table 53. Sanofi Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 54. Allergan Corporate Summary
    Table 55. Allergan Dermatophytic Onychomycosis Product Offerings
    Table 56. Allergan Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 57. Merz Pharma Corporate Summary
    Table 58. Merz Pharma Dermatophytic Onychomycosis Product Offerings
    Table 59. Merz Pharma Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 60. Xiuzheng Pharmaceutical Corporate Summary
    Table 61. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Product Offerings
    Table 62. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 63. Letai Corporate Summary
    Table 64. Letai Dermatophytic Onychomycosis Product Offerings
    Table 65. Letai Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
    Table 66. Qilu Pharmaceutical Corporate Summary
    Table 67. Qilu Pharmaceutical Dermatophytic Onychomycosis Product Offerings
    Table 68. Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue (US$, Mn), (2017-2022)
List of Figures
    Figure 1. Dermatophytic Onychomycosis Segment by Type in 2021
    Figure 2. Dermatophytic Onychomycosis Segment by Application in 2021
    Figure 3. Global Dermatophytic Onychomycosis Market Overview: 2021
    Figure 4. Key Caveats
    Figure 5. Global Dermatophytic Onychomycosis Market Size: 2021 VS 2028 (US$, Mn)
    Figure 6. Global Dermatophytic Onychomycosis Revenue, 2017-2028 (US$, Mn)
    Figure 7. The Top 3 and 5 Players Market Share by Dermatophytic Onychomycosis Revenue in 2021
    Figure 8. By Type - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    Figure 9. By Application - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    Figure 10. By Region - Global Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    Figure 11. By Country - North America Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    Figure 12. US Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 13. Canada Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 14. Mexico Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 15. By Country - Europe Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    Figure 16. Germany Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 17. France Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 18. U.K. Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 19. Italy Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 20. Russia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 21. Nordic Countries Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 22. Benelux Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 23. By Region - Asia Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    Figure 24. China Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 25. Japan Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 26. South Korea Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 27. Southeast Asia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 28. India Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 29. By Country - South America Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    Figure 30. Brazil Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 31. Argentina Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 32. By Country - Middle East & Africa Dermatophytic Onychomycosis Revenue Market Share, 2017-2028
    Figure 33. Turkey Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 34. Israel Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 35. Saudi Arabia Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 36. UAE Dermatophytic Onychomycosis Revenue, (US$, Mn), 2017-2028
    Figure 37. Johnson & Johnson Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 38. GSK Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 39. Novartis Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 40. Pfizer Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 41. Bausch Health Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 42. Kaken Pharmaceutical Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 43. Galderma Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 44. Sanofi Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 45. Allergan Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 46. Merz Pharma Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 47. Xiuzheng Pharmaceutical Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 48. Letai Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
    Figure 49. Qilu Pharmaceutical Dermatophytic Onychomycosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
61
Frequently Asked Questions
Dermatophytic Onychomycosis Market In Global report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Dermatophytic Onychomycosis Market In Global report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Dermatophytic Onychomycosis Market In Global report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports